Lupin seed γ-conglutin lowers blood glucose in hyperglycaemic rats and increases glucose consumption of HepG2 cells

Rosa Lovati, Maria; Manzoni, Cristina; Castiglioni, Silvia; Parolari, Anna; Magni, Chiara; Duranti, Marcello
January 2012
British Journal of Nutrition;2012, Vol. 107 Issue 1, p67
Academic Journal
The aim of the present study was to evaluate the effect of a chronic oral γ-conglutin treatment in male Sprague–Dawley rats in which hyperglycaemia had been induced by supplying 10 % d-glucose in drinking-water. A γ-conglutin dosage of 28 mg/kg body weight was daily administered to animals for 21 d. Plasma glucose, insulin and glucose overloading were monitored. Chronic administration of glucose resulted in a statistically significant (P < 0·05) increase in fasting blood glucose (2·5-fold) and insulin (2·7-fold) v. the values recorded in control rats. Simultaneous treatment with γ-conglutin attenuated the rise in plasma glucose (1·9-fold) and insulin (1·8-fold) levels in the glucose-fed rats (P < 0·05). Fasting insulin and homeostasis model of insulin resistance were decreased by 34 and 48 % (P < 0·05), respectively, in the γ-conglutin-treated rats v. the values found in pair-fed animals. To confirm these results with a different approach, HepG2 cells, grown for 24 and 48 h in Dulbecco's minimum essential medium containing different glucose concentrations (5·5, 11·1 and 16·5 mmol/l), were exposed to 10 μmol/l γ-conglutin with or without 10 mmol/l metformin or 100 nmol/l insulin. γ-Conglutin increased glucose consumption (from 1·5- to 2·5-fold) in HepG2 cells, under all experimental conditions; this effect was more evident after 48 h incubation. Moreover, in this in vitro model, the addition of γ-conglutin potentiated the activity of insulin and metformin in cell glucose consumption. These findings extend the previous ones and suggest the potential use of lupin γ-conglutin in the control of glycaemia.


Related Articles

  • Implantable, Continuous Sensor Reduced Glucose Fluctuations in Type 1 Diabetes.  // Ascribe Newswire: Medicine;3/4/2004, p9 

    Adults with type 1 diabetes experienced decreased periods of high or low blood sugar when using a long-term implantable, continuous glucose sensor, according to a study in the March issue of the journal Diabetes Care. Researchers at the University of Colorado Health Sciences Center's Barbara...

  • Glucose Transporter-1 in the Hypothalamic Glial Cells Mediates Glucose Sensing to Regulate Glucose Production In Vivo. Chari, Madhu; Yang, Clair S.; Lam, Carol K. L.; Lee, Katie; Mighiu, Patricia; Kokorovic, Andrea; Cheung, Grace W. C.; Lai, Teresa Y. Y.; Wang, Penny Y. T.; Lam, Tony K. T. // Diabetes;Jul2011, Vol. 60 Issue 7, p1901 

    OBJECTIVE -- Circulating glucose inhibits glucose production in normal rodents and humans, but this glucose effectiveness disrupted in diabetes due partly to sustained hyperglycemia. hypothesize that hyperglycemia in diabetes impairs hypothalamic glucose sensing to lower glucose production, and...

  • Glycated and Oxidized Protein Degradation Products Are Indicators of Fasting and Postprandial Hyperglycemia in Diabetes. Ahmed, Naila; Babaei-Jadidi, Roya; Howell, Scott K.; Thornalley, Paul J.; Beisswenger, Paul J. // Diabetes Care;Oct2005, Vol. 28 Issue 10, p2465 

    OBJECTIVE -- To assess the relative importance of fasting and postprandial hyperglycemia to vascular dysfunction in diabetes, we have measured indicators of glycation, oxidative and nitrosative stress in subjects with type 1 diabetes, and different postprandial glucose patterns. RESEARCH DESIGN...

  • Safety of glucose-containing solutions during accidental hyperinfusion in piglets. Witt, L.; Osthaus, W. A.; Lücke, T.; Jüttner, B.; Teich, N.; Jänisch, S.; Debertin, A. S.; Sümpelmann, R. // BJA: The British Journal of Anaesthesia;Nov2010, Vol. 105 Issue 5, p635 

    Background Errors in fluid management can lead to significant morbidity in children. We conducted an experimental animal study to determine the margin of safety in accidental hyperinfusion of different glucose and electrolyte containing solutions. Methods Fifteen piglets [bodyweight 12.1 (sd...

  • Hyperglycemia Lowers Seizure Threshold. Stafstrom, Carl E. // Epilepsy Currents;Jul2003, Vol. 3 Issue 4, p148 

    Comments on a study by E. M. Schwechter, J. Veliskova, and L. Velisek on the correlation between extracellular glucose and seizure susceptibility in adult rats. Method of the study; Effects of elevated extracellular glucose on epileptiform activity in vitro; Implication of the study findings...

  • MANEJO DE LA HIPERGLUCEMIA EN EL PACIENTE HOSPITALIZADO. Pasquel, Francisco J.; Umpierrez, Guillermo E. // Medicina (Buenos Aires);2010, Vol. 70 Issue 3, p275 

    Hyperglycemia is a frequent complication in patients admitted to the hospital, and it is associated with increased morbidity, mortality and length of stay. The mechanisms that cause these complications are not clear, but multiple physiological processes are affected with increased glucose...

  • Excessive glycation of pericapillary pericytic matrix components is an essential mechanism of arterial hypertension development in hyperglycemia. Shkolovoj, V. V.; Shkolovoj, S. V. // Bulletin of Experimental Biology & Medicine;Mar2011, Vol. 150 Issue 5, p572 

    In patients with essential hypertension, inhibition of glucose utilization in tissues was detected similar to that in diabetics. High levels of glycated compounds were found in cerebral, cardiac, and renal tissues of patients dead from coronary heart disease complicated and not complicated from...

  • The Effect of Pioglitazone on the Liver. Gastaldelli, Amalia; Miyazaki, Yoshinori; Mahankali, Archana; Berria, Rachele; Pettiti, Maura; Buzzigoli, Emma; Ferrannini, Eleuterio; DeFronzo, Ralph A. // Diabetes Care;Oct2006, Vol. 29 Issue 10, p2275 

    OBJECTIVE -- Diabetic hyperglycemia results from insulin resistance of peripheral tissues and glucose overproduction due to increased gluconeogenesis (GNG). Thiazolidinediones (TZDs) improve peripheral insulin sensitivity, but the effect on the liver is less clear. The goal of this study was to...

  • The Variability of Results Between Point-of-Care Testing Glucose Meters and the Central Laboratory Analyzer. Khan, Adil I.; Vasquez, Yolanda; Gray, Jacquelyn; Wians Jr, Frank H.; Kroll, Martin H. // Archives of Pathology & Laboratory Medicine;Oct2006, Vol. 130 Issue 10, p1527 

    Context.—Point-of-care testing glucose meters are strongly recommended in the management of diabetes and are increasingly being used for making therapeutically important decisions. Thus, it is essential that their results correlate well with those of laboratory analyzers....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics